A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival. Drugs known as statins are widely used to lower cholesterol and previous studies have indicated that they could be […]
News: Urologic CancersNext Page »
The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011. The report from the National Cancer Institute, a division of the National Institutes of Health, […]
Daniel Barocas, M.D., MPH, assistant professor of Urologic Surgery at Vanderbilt University Medical Center, was recently named a representative on the Commission on Cancer. The program helps to raise the quality of care at hospitals across the country through developing standards for cancer care and uses those standards to accredit hospitals. Barocas will represent the […]
Improvements in cancer diagnosis and treatment have led to longer survival for most cancer patients in the United States. However, the improvement in survival was substantially greater among younger patients and those who are white in most of the cancers studied, according to new research by Vanderbilt University investigators. The study was published online recently […]
Austin Kirschner, M.D., Ph.D., assistant professor of Radiation Oncology and Cancer Biology, has received the Urology Care Foundation Research Scholars Award for the study of advanced prostate cancer. “I am very honored to receive this important award in support of research to help men with difficult-to-treat forms of prostate cancer,” said Kirschner, who joined the […]
Vanderbilt-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.” Ostman, 63, who now lives in Hermitage, Tennessee, was sharing his story recently in a video for the nonprofit organization ZERO – The End of Prostate Cancer. The fact that he is still […]
Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.
Findings suggest a combination of therapies that may be effective in treating resistant prostate cancers
David Penson, M.D., will become chair of Vanderbilt’s Department of Urologic Surgery, effective Jan. 1, 2015.
Two urologic surgeons at Vanderbilt-Ingram Cancer Center are among a leading group of cancer physicians using an innovative new imaging agent and blue light system to “light up” cancerous cells inside the bladder. The combined system is used to confirm non-invasive papillary cancer inside the bladder and help surgeons detect and remove more of the […]